332 related articles for article (PubMed ID: 15738667)
1. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue.
Peterson B; Zhang J; Iglesias R; Kabo M; Hedrick M; Benhaim P; Lieberman JR
Tissue Eng; 2005; 11(1-2):120-9. PubMed ID: 15738667
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
[TBL] [Abstract][Full Text] [Related]
3. BMP-silk composite matrices heal critically sized femoral defects.
Kirker-Head C; Karageorgiou V; Hofmann S; Fajardo R; Betz O; Merkle HP; Hilbe M; von Rechenberg B; McCool J; Abrahamsen L; Nazarian A; Cory E; Curtis M; Kaplan D; Meinel L
Bone; 2007 Aug; 41(2):247-55. PubMed ID: 17553763
[TBL] [Abstract][Full Text] [Related]
4. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats.
Lieberman JR; Daluiski A; Stevenson S; Wu L; McAllister P; Lee YP; Kabo JM; Finerman GA; Berk AJ; Witte ON
J Bone Joint Surg Am; 1999 Jul; 81(7):905-17. PubMed ID: 10428121
[TBL] [Abstract][Full Text] [Related]
5. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats.
Hsu WK; Sugiyama O; Park SH; Conduah A; Feeley BT; Liu NQ; Krenek L; Virk MS; An DS; Chen IS; Lieberman JR
Bone; 2007 Apr; 40(4):931-8. PubMed ID: 17236835
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside.
Cuomo AV; Virk M; Petrigliano F; Morgan EF; Lieberman JR
J Bone Joint Surg Am; 2009 May; 91(5):1073-83. PubMed ID: 19411455
[TBL] [Abstract][Full Text] [Related]
9. BMP-2-transduced human bone marrow stem cells enhance neo-bone formation in a rat critical-sized femur defect.
Müller CW; Hildebrandt K; Gerich T; Krettek C; van Griensven M; Rosado Balmayor E
J Tissue Eng Regen Med; 2017 Apr; 11(4):1122-1131. PubMed ID: 25783748
[TBL] [Abstract][Full Text] [Related]
10. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects.
Bruder SP; Kraus KH; Goldberg VM; Kadiyala S
J Bone Joint Surg Am; 1998 Jul; 80(7):985-96. PubMed ID: 9698003
[TBL] [Abstract][Full Text] [Related]
11. Cell-based therapy by implanted human bone marrow-derived mononuclear cells improved bone healing of large bone defects in rats.
Seebach C; Henrich D; Schaible A; Relja B; Jugold M; Bönig H; Marzi I
Tissue Eng Part A; 2015 May; 21(9-10):1565-78. PubMed ID: 25693739
[TBL] [Abstract][Full Text] [Related]
12. The repair of critical-sized bone defects using expedited, autologous BMP-2 gene-activated fat implants.
Betz OB; Betz VM; Abdulazim A; Penzkofer R; Schmitt B; Schröder C; Mayer-Wagner S; Augat P; Jansson V; Müller PE
Tissue Eng Part A; 2010 Mar; 16(3):1093-101. PubMed ID: 20035609
[TBL] [Abstract][Full Text] [Related]
13. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
[TBL] [Abstract][Full Text] [Related]
14. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene.
Baltzer AW; Lattermann C; Whalen JD; Wooley P; Weiss K; Grimm M; Ghivizzani SC; Robbins PD; Evans CH
Gene Ther; 2000 May; 7(9):734-9. PubMed ID: 10822299
[TBL] [Abstract][Full Text] [Related]
15. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
16. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: evaluation in a rat segmental defect model.
Glatt V; Kwong FN; Park K; Parry N; Griffin D; Vrahas M; Evans CH; Harris M
J Orthop Trauma; 2009; 23(10):693-701. PubMed ID: 19858977
[TBL] [Abstract][Full Text] [Related]
17. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
18. Adipose-derived stem cells and BMP2: part 1. BMP2-treated adipose-derived stem cells do not improve repair of segmental femoral defects.
Chou YF; Zuk PA; Chang TL; Benhaim P; Wu BM
Connect Tissue Res; 2011 Apr; 52(2):109-18. PubMed ID: 20701464
[TBL] [Abstract][Full Text] [Related]
19. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
[TBL] [Abstract][Full Text] [Related]
20. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H
Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
